Moss Genomics Announces Strategic Investment in Genomes.io
June 19, 2025 8:00 AM EDT | Source: Moss Genomics Inc.
Vancouver, British Columbia–(Newsfile Corp. – June 19, 2025) – Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (OTCQB: MSSGF) (the “Company” or “Moss”) is pleased to announce that on June 18, 2025, it has entered into a non-binding term sheet for a strategic, non-controlling equity investment in Genomes.io Ltd. (“Genomes.io”), a UK-based company focused on secure, user-owned genomic data storage leveraging blockchain infrastructure.
Under the terms of the proposed investment, Moss would acquire a non-controlling equity interest in Genomes.io in exchange for 1,111,112 common shares of Moss, priced at $0.18 CAD per share (the “Moss Consideration Shares”). In connection with the…
